Geneos Wealth Management Inc. Aurinia Pharmaceuticals Inc. Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$5.94 - $11.27 $641 - $1,217	108 New	108 $1,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $20,812 - $38,718	-3,125 Reduced 96.66%	108 $0
Q2 2022 Jul 22, 2022	SELL	$8.95 - $12.8 $152 - $217	-17 Reduced 0.52%	3,233 $32,000
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $11,477 - $25,672	1,142 Added 54.17%	3,250 $40,000
Q3 2021 Nov 09, 2021	BUY	$10.93 - $23.55 $20,220 - $43,567	1,850 Added 717.05%	2,108 $45,000
Q2 2021 Jul 08, 2021	SELL	$10.0 - $14.52 $8,500 - $12,342	-850 Reduced 76.71%	258 $3,000
Q4 2020 May 19, 2021	BUY	$12.94 - $16.05 $14,337 - $17,783	1,108 New	1,108 $5,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.